| Registrars: | Capita Registrars |
| CEO: | Christina Coughlin |
| CFO: | Brian Hahn |
| Non-Executive Chairman: | Richard Hughes |
| Senior Independent Director: | Patrick Vink |
| Non-Executive Dir: | Paul Fry, Mark Goldberg, David Bryant |
| Address: | Scale Space, White City, Imperial College Campus, 58 Wood Lane, London, United Kingdom, LS23 7FA |
| Phone: | +44 (0)20 3911 0353 |
| Fax: | +44 (0)84 4414 0453 |
| Website: | http://avacta.com/ |
| Sector: | Pharma and Biotech(LSE) |
| Index: | FTSE AIM All-Share |
| Domestic Listings: | LSE:E3X1770 |
| ISIN: | GB00BYYW9G87 |
| Currency | UK Pounds |
| Share Price | 64.00p |
| Change Today | 0.000p |
| % Change | 0.00 % |
| 52 Week High | 89.50 |
| 52 Week Low | 46.00 |
| Volume | 266,922 |
| Shares Issued | 471.33m |
| Market Cap | £301.65m |
| Beta | 0.01 |
| RiskGrade | 461 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth |
|
|---|
| No dividends found |
| Time | Volume / Share Price |
| 16:19 | 5,000 @ 64.63p |
| 16:16 | 20,000 @ 64.63p |
| 16:11 | 62 @ 63.00p |
| 16:01 | 4,704 @ 63.93p |
| 15:12 | 1,592 @ 63.37p |
| CEO | Christina Coughlin |
| CFO | Brian Hahn |
You are here: research